Hundreds of clinical trials using cord blood stem cells are in progress. These are being done to advance hematopoietic stem cell transplantation for conditions like cerebral palsy, autism, traumatic brain injury, and pediatric stroke.
The cells in the cord tissue are being evaluated for their ability to minimize cord blood transplant complications by improving engraftment rates and reducing the risk of graft versus host disease (GvHD).
Recent laboratory research suggests promise across a variety of therapeutic areas including:
Spinal cord injury
And many more
Actual clinical trials are in progress evaluating cord tissue MSCs in a broad range of conditions including autoimmune disease, liver disease, orthopedic indications, and neurological conditions